Evidence map›Paper›PMID 42406073›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Subcortical dopamine D

Laust Vind Knudsen, Manouchehr Seyedi Vafaee, Ziba Ahangarani Farahani, Abigail Jane Sheldrick-Michel, Tanja Maria Michel

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laust Vind KnudsenPsychiatric Research Unit, Odense University Hospital, Odense, Denmark. lvk@sdu.dk.ORCID http://orcid.org/0000-0003-1674-3098
Manouchehr Seyedi VafaeePsychiatric Research Unit, Odense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0001-8409-7142
Ziba Ahangarani FarahaniDepartment of Nuclear Medicine, Odense University Hospital, 5000, Odense, Denmark.
Abigail Jane Sheldrick-MichelPsychiatric Research Unit, Odense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0003-4218-4621
Tanja Maria MichelPsychiatric Research Unit, Odense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0002-7181-6336

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDopaminergic signalling and glucose metabolism have been implicated in autism spectrum disorder (ASD), yet in vivo evidence in the human brain remains largely unexplored. This study examined subcortical dopamine D

methodsIn this dual-tracer PET/MR case-control study, 30 autistic and 30 neurotypical adults (age-, sex-, body mass index-, and IQ-matched) underwent [

resultsAutistic individuals demonstrated increased D

conclusionsThis study provides in vivo evidence of elevated subcortical D

Indexed as

Autistic DisorderBrainGlucoseMagnetic Resonance ImagingPositron-Emission TomographyReceptors, Dopamine D2AdultCase-Control StudiesDopaminergic ImagingFemaleFluorodeoxyglucose F18HumansMaleMultimodal ImagingYoung AdultFluorodeoxyglucose F18GlucoseReceptors, Dopamine D2AutismDopamineFunctional connectivityGlucose metabolismMRIPET

Identifiers

PMID42406073
PMCPMC13633290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.